The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.
Haematologica
; 104(3): 485-496, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30262569
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Gene Expression Regulation
/
Drug Resistance, Neoplasm
/
Cytarabine
/
NF-E2-Related Factor 2
/
Dual Specificity Phosphatase 1
/
Antimetabolites, Antineoplastic
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Haematologica
Year:
2019
Document type:
Article